Synovial chondromatosis is very rare, affecting roughly 1 to 1.8 people per million each year. To put that in perspective, a city of one million residents would expect to see only one or two new cases annually. The condition causes small, cartilage-covered nodules to form in the lining of a joint, and some of these nodules can break free and become loose bodies that interfere with movement.
How the Numbers Break Down
The most commonly cited figure comes from population data in England: approximately 1.8 cases per million people per year. Other estimates place it at about 1 case per 100,000, which works out to roughly 10 per million. The gap between these numbers reflects how difficult it is to track a condition that many people live with for years before receiving a correct diagnosis. Mild cases that cause only intermittent discomfort may never be formally identified.
Synovial chondromatosis overwhelmingly affects adults between 30 and 50 years old, though it can appear at any age. Men are diagnosed more often than women, with estimates of the male-to-female ratio ranging from about 2:1 up to 4:1. The reason for this skew isn’t fully understood.
Joints Most Commonly Affected
The knee accounts for 50% to 65% of all cases, making it the dominant location by a wide margin. The hip is the next most common site, followed by the shoulder and elbow. Less typical spots include the jaw joint, wrist, and small joints of the hand. Because the condition centers on the synovial membrane (the tissue that lines and lubricates joints), it can theoretically develop in any true joint, but it rarely does outside those major ones.
What It Feels Like
Joint pain and swelling are the hallmark complaints. Most people notice pain even at rest that worsens with movement. Beyond that, you may feel a grinding, popping, or creaking sensation when you bend or extend the joint. Some people can feel small bumps just under the skin near the affected area.
As the nodules grow or break loose inside the joint, they can physically block normal motion. This leads to stiffness, reduced range of movement, and sometimes a feeling of instability or difficulty bearing weight. A classic scenario is a knee that intermittently locks or catches, then frees itself. These symptoms often develop slowly over months or years, which is one reason diagnosis is frequently delayed.
Primary vs. Secondary Forms
There are two distinct types. Primary synovial chondromatosis arises on its own, without a clear underlying joint problem. The synovial lining spontaneously begins producing cartilage nodules for reasons that aren’t well understood. This is the rarer and more clinically significant form.
Secondary synovial chondromatosis develops as a response to existing joint damage, such as osteoarthritis, prior trauma, or other degenerative changes. Small fragments of damaged cartilage shed into the joint space and become loose bodies. Because it piggybacks on other common conditions, secondary cases are seen more frequently in clinical practice, though they’re still uncommon overall.
How It’s Diagnosed
Standard X-rays can reveal the condition when the cartilage nodules have calcified, appearing as multiple small, rounded opacities clustered inside a joint. About a third of cases don’t calcify enough to show on X-ray, so MRI is typically the more reliable tool. MRI can detect both calcified and non-calcified loose bodies, map their location inside the joint, and help distinguish synovial chondromatosis from other causes of joint pain. Because the condition is so uncommon, it’s frequently not the first diagnosis considered. Many patients go through months of treatment for more typical problems like meniscal tears or arthritis before the real cause is identified.
Risk of Becoming Cancerous
Primary synovial chondromatosis is a benign condition, but in roughly 1% to 6% of cases it can transform into a synovial chondrosarcoma, a type of cancer. This is a small but real risk, and it’s one reason doctors tend to recommend removal rather than observation when symptoms are present or the disease is progressing. Any sudden increase in pain, rapid joint swelling, or accelerated growth of nodules in someone with a known diagnosis warrants prompt re-evaluation.
Treatment and Recurrence
Surgery is the primary treatment when loose bodies are limiting joint function or damaging cartilage. The approach depends on the size and location of the nodules. Arthroscopic surgery, done through small incisions with a camera, is preferred when the nodules are confined inside the joint and reachable through standard port sites. Open surgery is reserved for cases with extensive involvement, very large nodules, or disease that has spread outside the joint capsule. Some cases require a combination of both techniques to fully clear the affected tissue.
Even after successful surgery, recurrence is a known possibility. In one study tracking outcomes after arthroscopic removal and synovectomy (removal of the affected joint lining), about 11% of patients experienced a confirmed recurrence, with the average time to recurrence being 3.6 years. Of those who recurred, only about half needed a second operation. Survivorship rates free from recurrence were 85% at eight years, meaning the majority of patients do well long-term after a single procedure.
When the disease does come back, it tends to follow the same pattern as the original case: gradual return of pain, stiffness, and mechanical symptoms. Repeat surgery carries similar success rates, and most recurrences remain benign. The small risk of malignant transformation, however, makes long-term follow-up with periodic imaging a reasonable approach for anyone who has been diagnosed.